KDDF’s Support Reflected In Robust R&D, Licensing By Korean Firms

Various government support schemes seem to have led to recent successful new drug development activities and licensing deals by South Korean pharma and biotech firms. The state-run Korea Drug Development Fund is seen as having played a key role in this effort, providing assistance to 153 R&D programs in the country so far to speed up development of novel and innovative global medicines.

Grants — KDDF Has Supported 153 Programs So Far • Source: Shutterstock

The state-run Korea Drug Development Fund (KDDF) has so far provided or is giving ongoing support to 153 innovative drug development programs in the pharma/biotech industry, universities or research institutes, with a goal of advancing South Korea’s development and commercialization of new drugs for the global market.

The fund, which is supported by multiple government ministries including health and welfare, has also been aiding the licensing out...